GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.11 by 26.13 percent. This is a 76.67 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $120.989 million which beat the analyst consensus estimate of $120.407 million by 0.48 percent. This is a 26.50 percent increase over sales of $95.640 million the same period last year.